Intertek Group PLC
30 March 2006
30 March 2006, 7am (UK)
Intertek Group plc ('Intertek')
INTERTEK ANNOUNCES NEW NON-EXECUTIVE DIRECTOR
Intertek Group plc is pleased to announce the appointment of Christopher Knight
as a Non-Executive Director with effect from 30 March 2006.
Chris Knight was an investment banker for nearly thirty years, for much of that
time with Morgan Grenfell and, after its takeover, with Deutsche Bank, of which
he was a managing director until 2001. He has wide ranging corporate finance
experience, both in the UK and internationally, having worked in the USA and the
Far East at various times in his career.
A Chartered Accountant, he is Chairman of Brooks Macdonald Group plc and Nelson
Bakewell Group Limited and a Non-Executive Director of Lloyds Register Holdings.
He was also a director of Anker plc until August 2005.
Under the UK Listing Rules, the Company is required to make the following
disclosure:
There are no further details that are required to be disclosed as required under
paragraph LR 9.6.13 R of the UK Listing Rules in respect of Christopher Knight.
Vanni Treves, Chairman said:
'I am delighted to announce the appointment of Chris to the Board. His extensive
experience as a corporate financier will strengthen the Board and assist in the
continued growth of Intertek. '
For further information, please contact
Aston Swift, Investor Relations
Telephone: +44 (0) 20 7396 3400 aston.swift@intertek.com
Tim Lynch, Tulchan Communications
Telephone: +44 (0) 20 7353 4200 intertekteam@tulchangroup.com
Corporate website: www.intertek.com
High resolution images of Intertek Group plc businesses are available to
download, free of charge from www.vismedia.co.uk.
ABOUT INTERTEK
Intertek is a leading international provider of quality and safety services to a
wide range of global and local industries. Partnership with Intertek brings
increased value to customers' products, processes and ultimately supports their
success in the global market place. Intertek has the experience, expertise,
resources and global reach to support their customers through their network of
over 850 laboratories and offices and 15,500 people in more than 100 countries
around the world.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.